Q4 2018 Evofem Biosciences Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to Evofem Biosciences Conference Call. (Operator Instructions)
I would now like to introduce your host for today's conference, Amy Raskopf. Please begin.
Thank you, Norma. Good morning, everyone. And thanks for joining the Evofem Biosciences Fourth Quarter and Year-End 2018 Financial Results. This is Amy Raskopf, Investor Relations for Evofem.
If you have not already received it, please access the financial results press release issued earlier this morning on our website, evofem.com under Investors. A webcast of today's call is available there as well.
Various statements we make during this call about Evofem's business, strategy and plans are considered forward-looking statements for the purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous assumptions, risks and uncertainties which change overtime. Further information on the factors and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |